Evidence map›Paper›PMID 40119759›Full record

ArticleACS chemical biology2025

Synthesis of Differentially Halogenated Lissoclimide Analogues To Probe Ribosome E-Site Binding.

Salvatore Terrosu, Liliia Nurullina, Nantamon Supantanapong, Bonnie S Pak, Sierra Nguyen, Mikael Holm, Cheng Wu, Min Lin, David Horne, Matthew S Sachs and 3 more

Abstract read
In one paragraph

Article in ACS chemical biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Salvatore TerrosuINSERM U964, CNRS UMR7104, Université de Strasbourg, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), 67404 Illkirch, France.
Liliia NurullinaINSERM U964, CNRS UMR7104, Université de Strasbourg, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), 67404 Illkirch, France.
Nantamon SupantanapongDepartment of Chemistry, 1102 Natural Sciences II, University of California, Irvine, Irvine, California 92697-2025, United States.
Bonnie S PakDepartment of Chemistry, 1102 Natural Sciences II, University of California, Irvine, Irvine, California 92697-2025, United States.
Sierra NguyenDepartment of Chemistry, 1102 Natural Sciences II, University of California, Irvine, Irvine, California 92697-2025, United States.
Mikael HolmDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105-3678, United States.
Cheng WuDepartment of Biology, Texas A&M University, College Station, Texas 77843-3258, United States.
Min LinDepartment of Molecular Medicine, Beckman Research Institute, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, California 91010, United States.
David HorneDepartment of Molecular Medicine, Beckman Research Institute, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, California 91010, United States.
Matthew S SachsDepartment of Biology, Texas A&M University, College Station, Texas 77843-3258, United States.ORCID 0000-0001-9891-9223
Scott C BlanchardDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105-3678, United States.ORCID 0000-0003-2717-9365
Marat YusupovINSERM U964, CNRS UMR7104, Université de Strasbourg, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), 67404 Illkirch, France.
Christopher D VanderwalDepartment of Chemistry, 1102 Natural Sciences II, University of California, Irvine, Irvine, California 92697-2025, United States.ORCID 0000-0001-7218-4521

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI John Charles Williams · 1985 to 2026
$86.3M
Imaging Protein Synthesis on the Ribosome using Single-Molecule FRETR01GM079238 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI BLANCHARD, SCOTT C · 2006 to 2023
$7.0M
Chemical Synthesis of Bioactive DiterpenoidsR35GM145252 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI Christopher D Vanderwal · 2022 to 2026
$2.1M
Cyclization Cascades to Access Bioactive DiterpenoidsR01GM129264 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI VANDERWAL, CHRISTOPHER D · 2018 to 2021
$1.6M
Determining genetic signatures of the cryptococcal response to Zoloft by an integrated approach combining transcriptome, translatome and genetic screensR21AI138158 · NIAID · TEXAS A&M UNIVERSITY · PI LIN, XIAORONG, SACHS, MATTHEW STEVEN · 2018 to 2019
$395k
NCI NIH HHS P30 CA033572NIAID NIH HHS R21 AI138158NIGMS NIH HHS R01 GM079238NIGMS NIH HHS R01 GM129264NIGMS NIH HHS R35 GM145252
6 · The paper itself

Abstract

Halogenated natural products from marine sources often demonstrate potent activity against microorganisms and cancer cell lines. During the last three decades, the lissoclimide class of chlorinated labdane diterpenoids has been characterized with respect to structure and cytotoxic activity. Recently, our laboratories have developed different strategies to produce a broad range of naturally occurring lissoclimides and designed synthetic analogues. This work led to the discovery of a novel halogen-π dispersion interaction between the C2 chloride of chlorolissoclimide and guanine residues in the tRNA exit (E) site of the ribosome. In this study, we aimed to synthesize lissoclimide analogues bearing different substituents in place of the chloride to investigate the importance of the halogen identity for binding, translation inhibition, and cytotoxicity. With previous access to the protio and chloro compounds (haterumaimide Q and chlorolissoclimide), we synthesized two more halogenated variants, fluorolissoclimide and bromolissoclimide, as well as a methylated analogue, methyllissoclimide, to complete a panel of chemical probes for functional and structural studies. Using an integrative approach, we explored the effects of these analogues on the eukaryotic translational machinery in vivo and in vitro. X-ray cocrystal structures with the eukaryotic ribosome were solved for each probe molecule, and the effects on ribosomal thermal stability and FRET-derived ribosome binding constants were determined. Together, these data provide a detailed understanding of the different modes of binding of lissoclimides and insight into their relative activities, which vary according to the substitutions that interact with the eukaryote-specific ribosomal protein eL42. Ultimately, we learned that the presence of a lissoclimide C2-halogen atom─offering a potentially stabilizing halogen-π interaction─appears to facilitate or to synergize with a hydrogen-bonding interaction between the C7-hydroxyl group and the backbone of the ribosomal protein eL42, leading to stronger translation inhibition. We therefore conclude that the C2-halogen and C7-hydroxyl groups are critical contributors to potency, and this idea is borne out in the observations of reduced biological activities in the absence of either group.

Indexed as

DiterpenesRibosomesBinding SitesHalogenationHumansRNA, TransferDiterpenesRNA, Transfer

Identifiers

PMID40119759
PMCPMC12012676

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.